Aqua Bio Technology ASA

kr 4.38As of Sun 8 Nov 2026, 12:00 UTC
OSL:ABTECHealthcare
Country Norway
PE (Fwd) •••
TSR 10Y CAGR (37.59%)
Div yield —
ROE (115.14%)
Biotechnology
Beta (5Y) 0.26
PE TTM —
TSR TTM (82.48%)
Mkt cap kr 65.56M
ROIC (4.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 5.36
22.32%
305.81%
Hold 11|12|11|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.07
0.08
0.08
0.09
10.49%
23.11%
20.20%
28.12%
Revenuekr M
3.530
3.542
3.597
3.667
8.97%
4.42%
3.37%
6.38%
Peers (US$6.934M)
Cap (US$)
PE
40.58M
—
Capital
TTM
5Y
10Y
Leveragex
8.411
0.712
0.661
EBIT/Intx
3.225
0.307
0.325
Own earn%
4.66
19.96
20.43
Sh yield%
21.08
9.57
10.24
Owners
Insiders/Inst%
2.99
67.28
Short interest%
2.44
SBC / revenue%
1.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
7–12
$1 testx
—
Incr. ROIC%
3